Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$179.56
0.440.25%
al cierre: Nov 21, 4:00 PM EST
$179.56
N/A
After hour: 4:24 PM EST
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
American Tower Corp tiene un precio objetivo de consenso de $234.96 basado en las calificaciones de 28 analistas. El máximo es $275, emitido por Truist Securities el enero 13, 2023. El mínimo es $200, emitido por Wells Fargo el octubre 29, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por Barclays, JP Morgan y Wells Fargo el noviembre 17, 2025, octubre 29, 2025 y octubre 29, 2025, respectivamente. Con un precio objetivo promedio de $217.67 entre Barclays, JP Morgan y Wells Fargo, hay una 21.22% upside implícita para American Tower Corp según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Barclays
JP Morgan
Wells Fargo
Raymond James
BMO Capital
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para American Tower
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/17/2025 | 13.05% | Barclays | $251 → $203 | Maintains | Overweight | |||
10/29/2025 | 39.23% | JP Morgan | $255 → $250 | Maintains | Overweight | |||
10/29/2025 | 11.38% | Wells Fargo | $210 → $200 | Maintains | Overweight | |||
10/29/2025 | 28.65% | Raymond James | $250 → $231 | Reiterates | Strong Buy → Strong Buy | |||
10/29/2025 | 19.74% | BMO Capital | $220 → $215 | Maintains | Outperform | |||
10/20/2025 | 16.95% | Wells Fargo | $230 → $210 | Maintains | Overweight | |||
10/17/2025 | 39.79% | Barclays | $250 → $251 | Maintains | Overweight | |||
10/16/2025 | 30.88% | Morgan Stanley | $270 → $235 | Maintains | Overweight | |||
10/16/2025 | 25.31% | Citigroup | $250 → $225 | Maintains | Buy | |||
10/02/2025 | 22.52% | RBC Capital | $260 → $220 | Downgrade | Outperform → Sector Perform | |||
08/18/2025 | 39.23% | Barclays | $246 → $250 | Maintains | Overweight | |||
07/31/2025 | 44.8% | RBC Capital | $250 → $260 | Maintains | Outperform | |||
07/30/2025 | 39.23% | Raymond James | $251 → $250 | Maintains | Strong Buy | |||
07/30/2025 | 28.09% | Wells Fargo | $240 → $230 | Maintains | Overweight | |||
07/30/2025 | 42.01% | JP Morgan | $250 → $255 | Maintains | Overweight | |||
07/30/2025 | 36.44% | BMO Capital | $250 → $245 | Maintains | Outperform | |||
07/23/2025 | 37% | Barclays | $223 → $246 | Maintains | Overweight | |||
07/08/2025 | 44.8% | UBS | $250 → $260 | Maintains | Buy | |||
05/01/2025 | 39.23% | RBC Capital | $240 → $250 | Maintains | Outperform | |||
04/30/2025 | 34.22% | TD Cowen | $239 → $241 | Maintains | Buy | |||
04/30/2025 | 38.12% | Scotiabank | $234 → $248 | Maintains | Sector Outperform | |||
04/30/2025 | 33.66% | Wells Fargo | $230 → $240 | Maintains | Overweight | |||
04/30/2025 | 44.8% | JMP Securities | $248 → $260 | Maintains | Market Outperform | |||
04/30/2025 | 39.79% | Raymond James | $231 → $251 | Maintains | Strong Buy | |||
04/30/2025 | 39.23% | UBS | $245 → $250 | Maintains | Buy | |||
04/22/2025 | 30.32% | Scotiabank | $220 → $234 | Maintains | Sector Outperform | |||
04/01/2025 | 39.23% | Morgan Stanley | $213 → $250 | Upgrade | Equal-Weight → Overweight | |||
03/21/2025 | 24.19% | Barclays | $214 → $223 | Maintains | Overweight | |||
03/17/2025 | 28.09% | Wells Fargo | $210 → $230 | Upgrade | Equal-Weight → Overweight | |||
03/10/2025 | 30.88% | Citigroup | $220 → $235 | Maintains | Buy | |||
02/26/2025 | 38.12% | Citizens Capital Markets | $225 → $248 | Maintains | Market Outperform | |||
02/26/2025 | 22.52% | BMO Capital | $210 → $220 | Maintains | Outperform | |||
02/24/2025 | 18.62% | Morgan Stanley | $219 → $213 | Maintains | Equal-Weight | |||
02/24/2025 | 25.31% | Citizens Capital Markets | $225 → $225 | Reiterates | Market Outperform → Market Outperform | |||
02/14/2025 | 22.52% | Citigroup | $255 → $220 | Maintains | Buy | |||
01/28/2025 | 19.18% | Barclays | $215 → $214 | Maintains | Overweight | |||
01/27/2025 | 25.31% | JMP Securities | → $225 | Initiates | → Market Outperform | |||
01/23/2025 | 22.52% | Scotiabank | $236 → $220 | Maintains | Sector Outperform | |||
01/23/2025 | 8.6% | Wells Fargo | $215 → $195 | Maintains | Equal-Weight | |||
01/13/2025 | 19.74% | Barclays | $251 → $215 | Maintains | Overweight | |||
01/08/2025 | 13.61% | Mizuho | $221 → $204 | Maintains | Neutral | |||
12/12/2024 | 30.32% | Goldman Sachs | $260 → $234 | Maintains | Buy | |||
11/18/2024 | 39.79% | Barclays | $255 → $251 | Maintains | Overweight | |||
10/30/2024 | 31.43% | Scotiabank | $248 → $236 | Maintains | Sector Outperform | |||
10/30/2024 | 36.44% | BMO Capital | $255 → $245 | Maintains | Outperform | |||
10/10/2024 | 42.01% | Barclays | $223 → $255 | Maintains | Overweight | |||
10/10/2024 | 28.09% | Wells Fargo | $245 → $230 | Downgrade | Overweight → Equal-Weight | |||
09/23/2024 | 39.23% | JP Morgan | $240 → $250 | Maintains | Overweight | |||
09/13/2024 | 44.8% | BMO Capital | $246 → $260 | Maintains | Outperform | |||
09/12/2024 | 23.08% | Mizuho | $205 → $221 | Maintains | Neutral | |||
08/15/2024 | 31.43% | RBC Capital | $225 → $236 | Maintains | Outperform | |||
08/14/2024 | 30.88% | Deutsche Bank | $212 → $235 | Maintains | Buy | |||
07/31/2024 | 38.12% | Scotiabank | $223 → $248 | Maintains | Sector Outperform | |||
07/31/2024 | 33.1% | TD Cowen | $226 → $239 | Maintains | Buy | |||
07/31/2024 | 36.44% | Wells Fargo | $225 → $245 | Maintains | Overweight | |||
07/31/2024 | 37% | BMO Capital | $225 → $246 | Maintains | Outperform | |||
07/31/2024 | 33.66% | JP Morgan | $230 → $240 | Maintains | Overweight | |||
07/15/2024 | 25.31% | Wells Fargo | $200 → $225 | Maintains | Overweight | |||
07/01/2024 | 28.09% | Goldman Sachs | → $230 | Initiates | → Buy | |||
05/30/2024 | 24.19% | Barclays | $234 → $223 | Maintains | Overweight | |||
05/01/2024 | 24.19% | Scotiabank | $243 → $223 | Maintains | Sector Outperform | |||
05/01/2024 | 22.52% | BMO Capital | $228 → $220 | Maintains | Outperform | |||
05/01/2024 | 38.12% | Raymond James | $226 → $248 | Upgrade | Outperform → Strong Buy | |||
04/15/2024 | 9.16% | Morgan Stanley | $183 → $196 | Maintains | Equal-Weight | |||
04/08/2024 | 14.17% | Mizuho | → $205 | Initiates | → Neutral | |||
03/05/2024 | 30.32% | Barclays | $224 → $234 | Maintains | Overweight | |||
02/28/2024 | 28.09% | JP Morgan | $236 → $230 | Maintains | Overweight | |||
02/28/2024 | 26.98% | BMO Capital | $235 → $228 | Maintains | Outperform | |||
01/24/2024 | 24.75% | Barclays | $229 → $224 | Maintains | Overweight | |||
12/14/2023 | 36.44% | HSBC | → $245 | Initiates | → Buy | |||
11/07/2023 | 13.61% | RBC Capital | $193 → $204 | Maintains | Outperform | |||
11/07/2023 | 31.43% | JP Morgan | $218 → $236 | Maintains | Overweight | |||
10/17/2023 | 11.38% | Citigroup | $230 → $200 | Maintains | Buy | |||
10/17/2023 | 16.95% | Wells Fargo | $215 → $210 | Maintains | Overweight | |||
10/16/2023 | -5.88% | Morgan Stanley | $212 → $169 | Maintains | Equal-Weight | |||
09/27/2023 | 21.41% | JP Morgan | $265 → $218 | Maintains | Overweight | |||
09/14/2023 | 18.07% | Morgan Stanley | $213 → $212 | Maintains | Equal-Weight | |||
08/22/2023 | 14.17% | Raymond James | $211 → $205 | Maintains | Outperform | |||
08/07/2023 | 26.98% | Barclays | $233 → $228 | Maintains | Overweight | |||
08/01/2023 | 28.09% | RBC Capital | $233 → $230 | Maintains | Outperform | |||
07/28/2023 | 17.51% | Raymond James | $238 → $211 | Maintains | Outperform | |||
07/18/2023 | 19.74% | Wells Fargo | $245 → $215 | Maintains | Overweight | |||
07/13/2023 | 28.09% | BMO Capital | → $230 | Initiates | → Outperform | |||
05/17/2023 | 18.62% | Morgan Stanley | $215 → $213 | Maintains | Equal-Weight | |||
05/01/2023 | 29.76% | Barclays | $229 → $233 | Maintains | Overweight | |||
04/27/2023 | 32.55% | Raymond James | $227 → $238 | Maintains | Outperform | |||
04/18/2023 | 19.74% | Morgan Stanley | $224 → $215 | Maintains | Equal-Weight | |||
03/30/2023 | 30.32% | MoffettNathanson | $244 → $234 | Upgrade | Market Perform → Outperform | |||
03/23/2023 | 27.53% | Barclays | $246 → $229 | Maintains | Overweight | |||
03/07/2023 | 35.89% | Jefferies | $239 → $244 | Maintains | Buy | |||
03/06/2023 | 28.09% | RBC Capital | $240 → $230 | Maintains | Outperform | |||
03/02/2023 | 22.52% | Argus Research | $250 → $220 | Maintains | Buy | |||
02/24/2023 | 50.92% | TD Cowen | $279 → $271 | Maintains | Outperform | |||
02/24/2023 | 26.42% | Raymond James | $233 → $227 | Maintains | Outperform | |||
02/24/2023 | 35.89% | Credit Suisse | $251 → $244 | Maintains | Outperform | |||
02/08/2023 | 37% | Barclays | $247 → $246 | Maintains | Overweight | |||
01/23/2023 | 24.75% | Morgan Stanley | $219 → $224 | Maintains | Equal-Weight | |||
01/23/2023 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
01/13/2023 | 53.15% | Truist Securities | $325 → $275 | Maintains | Buy | |||
01/12/2023 | 41.46% | Deutsche Bank | $240 → $254 | Upgrade | Hold → Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de American Tower (AMT)?
El último precio objetivo de American Tower (NYSE:AMT) fue comunicado por Barclays el noviembre 17, 2025. La firma de analistas fijó un precio objetivo para $203.00 que espera AMT a rise dentro de 12 meses (un posible 13.05% upside). 42 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre American Tower (AMT)?
La última calificación de analistas para American Tower (NYSE:AMT) fue proporcionada por Barclays, y American Tower mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de American Tower (AMT)?
La última revisión al alza de American Tower Corp se produjo en abril 1, 2025, cuando Morgan Stanley elevó su precio objetivo a $250. Morgan Stanley anteriormente tenía an equal-weight para American Tower Corp.
¿Cuándo fue la última revisión a la baja de American Tower (AMT)?
La última revisión a la baja de American Tower Corp se produjo en octubre 2, 2025, cuando RBC Capital cambió su precio objetivo de $260 a $220 para American Tower Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para American Tower (AMT)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de American Tower, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de American Tower se registró el noviembre 17, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 17, 2026.
¿Es correcta la calificación de los analistas sobre American Tower (AMT)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de American Tower (AMT) fue un mantuvo con un precio objetivo de $251.00 a $203.00. El precio actual al que cotiza American Tower (AMT) es de $179.56, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.